Garland J S, Chan Y M, Kelly K J, Rice T B
Critical Care Section, Children's Hospital, Milwaukee 53226.
Chest. 1989 Jul;96(1):136-8. doi: 10.1378/chest.96.1.136.
Previous studies have documented a 75 to 80 percent mortality rate in infants (less than 12 months) with cystic fibrosis who present with RF/MV. We investigated the current outcome of these patients by comparing the outcome of five infants with cystic fibrosis and RF/MV between the years 1980 and 1986 with that of age-matched control subjects with cystic fibrosis and no respiratory failure. Recent Shwachman scores and the number of hospitalizations during the study period were used to assess outcome. All study cases were alive one to six years after the episode of RF/MV. Their mean Shwachman score (83 [range: 70 to 95]) did not differ from the recent mean Shwachman score (78 [range: 50 to 95]) of the control group. Number of hospitalizations did not differ between groups. We conclude that the outcome of infants with cystic fibrosis whose initial presentation is RF/MV is not as grave as once thought. If indicated, infants with cystic fibrosis and respiratory failure should be ventilated.
以往研究记录显示,患有囊性纤维化且出现呼吸衰竭/机械通气的婴儿(小于12个月)死亡率为75%至80%。我们通过比较1980年至1986年间5例患有囊性纤维化且出现呼吸衰竭/机械通气的婴儿与年龄匹配的无呼吸衰竭的囊性纤维化对照受试者的结局,来研究这些患者目前的转归情况。采用近期的施瓦克曼评分以及研究期间的住院次数来评估转归情况。所有研究病例在呼吸衰竭/机械通气发作后的1至6年仍存活。他们的平均施瓦克曼评分(83[范围:70至95])与对照组近期的平均施瓦克曼评分(78[范围:50至95])并无差异。两组间的住院次数也无差异。我们得出结论,初始表现为呼吸衰竭/机械通气的囊性纤维化婴儿的转归并不像曾经认为的那样严重。如有指征,患有囊性纤维化和呼吸衰竭的婴儿应接受通气治疗。